Latest current assets for ZYME: $300B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Zymeworks BC (ZYME) currently reports a current assets of $300B as of June 2026. That compares with $300M in the prior-year period — up 100662.5% year over year. Use the charts on this page to explore Zymeworks BC's current assets history and peer comparisons.
Zymeworks BC's current assets increased from $300M to $300B — a 100662.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zymeworks BC reported $300B in current assets as of June 2026. That compares with $300M in the prior-year period — up 100662.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $300B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zymeworks BC, and consider following ZYME for alerts when major investors trade the stock.
Zymeworks BC is classified in the Healthcare sector. On current assets, it currently shows $300B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZYME with unrelated industries.